Search Results - "Berdiel Acer, Mireia"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    IFNβ1 secreted by breast cancer cells undergoing chemotherapy reprograms stromal fibroblasts to support tumour growth after treatment by Maia, Ana, Gu, Zuguang, Koch, André, BerdielAcer, Mireia, Will, Rainer, Schlesner, Matthias, Wiemann, Stefan

    Published in Molecular oncology (01-05-2021)
    “…Chemotherapy (CTX) remains the standard of care for most aggressive tumours, including breast cancer (BC). In BC chemotherapeutic regimens, the maximum…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Abstract PS16-36: Paracrine signalling with stromal fibroblasts drives recovery of cancer cells after chemotherapy treatment by Maia, Ana, Gu, Zuguang, Koch, André, Berdiel-Acer, Mireia, Will, Rainer, Schlesner, Matthias, Wiemann, Stefan

    Published in Cancer research (Chicago, Ill.) (15-02-2021)
    “…Abstract Introduction: The main cause of death for cancer patients is the development of metastasis. These arise mainly due to irresponsiveness of cancer cells…”
    Get full text
    Journal Article
  9. 9

    Abstract P1-08-15: Communication between tumor cells and fibroblasts as a prognostic factor of NACT in TNBC by Bauer, Marcus, Vetter, Martina, Maia, Ana, Vlachavas, Efstathios, Michels, Brigitta, Berdiel-Acer, Mireia, Schüler, Kathleen, Morselli, Alessandra, Skarlatou, Manio, Thomssen, Christoph, Wiemann, Stefan

    Published in Cancer research (Chicago, Ill.) (15-02-2022)
    “…Abstract Introduction. Neoadjuvant chemotherapy (NACT) is the standard of care in aggressive breast cancer, including triple negative breast cancer (TNBC)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Abstract 3329: Combinatorial blockade of ERBB receptors in HER2 low breast cancer by Berdiel-Acer, Mireia, Reinz, Eileen, Abnaof, Khalid, Burmester, Sara, Will, Rainer, Korf, Ulrike, Wiemann, Stefan

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Large number of breast cancer patients clinically classified as HER2 negative, show low/moderate levels of HER2 along with other ERBB receptors…”
    Get full text
    Journal Article
  12. 12

    Disentangling ERBB Signaling in Breast Cancer Subtypes-A Model-Based Analysis by Kemmer, Svenja, Berdiel-Acer, Mireia, Reinz, Eileen, Sonntag, Johanna, Tarade, Nooraldeen, Bernhardt, Stephan, Fehling-Kaschek, Mirjam, Hasmann, Max, Korf, Ulrike, Wiemann, Stefan, Timmer, Jens

    Published in Cancers (12-05-2022)
    “…Targeted therapies have shown striking success in the treatment of cancer over the last years. However, their specific effects on an individual tumor appear to…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15